HTA - 09/104/40

Health-Related Quality of Life in two treatment pathways for newly diagnosed open angle glaucoma and ocular hypertension: an unmasked, multi-centre, randomised controlled trial of initial selective laser trabeculoplasty versus conventional medical therapy

Project title: Health-Related Quality of Life in two treatment pathways for newly diagnosed open angle glaucoma and ocular hypertension: an unmasked, multi-centre, randomised controlled trial of initial selective laser trabeculoplasty versus conventional medical therapy

Call to action: 09/104 HTA Clinical Trials April 2010 Board submissions (October 09 deadline)

Research type: Primary Research

Chief investigator: Professor Gus Gazzard

Contractor: Moorfields Eye Hospital NHS Foundation Trust

Cost: £1,953,945.00

Co-investigators: Dr Catey Bunce, Dr Gareth Ambler, Dr Marta Buszewicz, Dr Rachael Hunter, Mr Keith Barton, Mr Richard Wormald, Professor David Garway-Heath, Professor Gary Rubin, Professor Stephen Morris.

Started: September 2012 | Status: Research in progress

ISRCTN: 32038223

Selective laser trabeculoplasty achieved comparable health-related quality of life to eye drops and at lower cost.

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.